Published in Am J Kidney Dis on January 04, 2013
Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant (2015) 0.78
Stem cell-based cell therapy for glomerulonephritis. Biomed Res Int (2014) 0.77
Graft versus host disease-dependent renal dysfunction after hematopoietic stem cell transplantation. CEN Case Rep (2014) 0.75
Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants. Bone Marrow Transplant (2017) 0.75
A Perspective on Chronic Kidney Disease Progression. Am J Physiol Renal Physiol (2016) 0.75
Addressing the Symptoms or Fixing the Problem? Developing Countermeasures against Normal Tissue Radiation Injury. Radiat Res (2016) 0.75
Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series. Mod Pathol (2016) 0.75
Radiation-induced afferent arteriolar endothelial-dependent dysfunction involves decreased epoxygenase metabolites. Am J Physiol Heart Circ Physiol (2016) 0.75
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science (2005) 17.00
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int (2011) 4.51
Management of glomerular proteinuria: a commentary. J Am Soc Nephrol (2003) 2.59
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A (2002) 2.31
Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol (2005) 1.90
A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int (2011) 1.77
Activation of the Nrf2/antioxidant response pathway increases IL-8 expression. Eur J Immunol (2005) 1.74
Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) (2011) 1.70
Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma. Nat Clin Pract Nephrol (2007) 1.63
Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract (2010) 1.62
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol (2009) 1.57
Tolerating increases in the serum creatinine following aggressive treatment of chronic kidney disease, hypertension and proteinuria: pre-renal success. Am J Nephrol (2012) 1.57
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther (2009) 1.54
Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int (2008) 1.51
Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum (2012) 1.32
Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol (2006) 1.26
A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet (2007) 1.25
A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis. Kidney Int (2009) 1.24
Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol (2011) 1.17
The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun (2004) 1.15
Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2007) 1.13
Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort. Arthritis Rheumatol (2015) 1.09
Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis. J Am Soc Nephrol (2004) 1.05
Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum (2005) 1.05
Random spot urine protein/creatinine ratio is unreliable for estimating 24-hour proteinuria in individual systemic lupus erythematosus nephritis patients. Nephron Clin Pract (2009) 1.05
Statin use and calcific uremic arteriolopathy: a matched case-control study. Am J Nephrol (2013) 1.04
Rituximab treatment of fibrillary glomerulonephritis. Am J Kidney Dis (2008) 1.02
The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production. Cytokine (2002) 1.01
Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines. Biochim Biophys Acta (2010) 0.99
Induction of chemokine expression by adiponectin in vitro is isoform dependent. Transl Res (2009) 0.98
N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy. Am J Physiol Renal Physiol (2013) 0.98
Mycophenolate therapy of SLE membranous nephropathy. Kidney Int (2004) 0.97
Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications. Clin J Am Soc Nephrol (2008) 0.97
Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele. Arthritis Rheum (2006) 0.96
Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells. Kidney Int (2004) 0.95
Mathematical modeling of prostate cancer progression in response to androgen ablation therapy. Proc Natl Acad Sci U S A (2011) 0.95
Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index. Arthritis Rheum (2008) 0.94
Chemokines: therapeutic targets for autoimmune and inflammatory renal disease. Springer Semin Immunopathol (2003) 0.94
Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. Arthritis Rheum (2008) 0.94
Colon biopsies for evaluation of acute graft-versus-host disease (A-GVHD) in allogeneic bone marrow transplant patients. BMC Gastroenterol (2003) 0.93
A quantitative proteomic workflow for characterization of frozen clinical biopsies: laser capture microdissection coupled with label-free mass spectrometry. J Proteomics (2012) 0.92
APOE Kyoto mutation in European Americans with lipoprotein glomerulopathy. N Engl J Med (2007) 0.91
Epidermal growth factor and interleukin-1beta utilize divergent signaling pathways to synergistically upregulate cyclooxygenase-2 gene expression in human amnion-derived WISH cells. Biol Reprod (2004) 0.91
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis. Arthritis Rheumatol (2014) 0.91
A mathematical model of venous neointimal hyperplasia formation. Theor Biol Med Model (2008) 0.91
The death domain of kidney ankyrin interacts with Fas and promotes Fas-mediated cell death in renal epithelia. J Am Soc Nephrol (2004) 0.91
Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option. Clin J Am Soc Nephrol (2009) 0.88
High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2013) 0.87
Glomerular disease: Lupus nephritis treatment: are we beyond cyclophosphamide? Nat Rev Nephrol (2009) 0.87
Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells. Biol Reprod (2005) 0.87
Characterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli. Mod Pathol (2012) 0.86
Diagnostic accuracy study of urine dipstick in relation to 24-hour measurement as a screening tool for proteinuria in lupus nephritis. J Rheumatol (2007) 0.86
Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular disease. Ann Rheum Dis (2013) 0.86
Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers. Theor Biol Med Model (2010) 0.85
Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy. Pharmacotherapy (2010) 0.85
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR). Nephron (2015) 0.85
Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review. Rheumatol Int (2008) 0.85
Beyond anemia: hepcidin, monocytes and inflammation. Biol Chem (2013) 0.84
Single and combination toxic metal exposures induce apoptosis in cultured murine podocytes exclusively via the extrinsic caspase 8 pathway. Toxicol Sci (2006) 0.84
Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects. Adv Exp Med Biol (2006) 0.84
When size matters: diagnostic value of kidney biopsy according to the gauge of the biopsy needle. Am J Nephrol (2013) 0.83
Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus. Mol Immunol (2012) 0.82
Diagnostic utility of kidney biopsy in patients with sarcoidosis and acute kidney injury. Int J Nephrol Renovasc Dis (2011) 0.82
Differential diagnosis of glomerular disease: a systematic and inclusive approach. Am J Nephrol (2013) 0.81
Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis. Clin J Am Soc Nephrol (2013) 0.81
The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort. Nat Clin Pract Nephrol (2007) 0.80
Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide. Nephrol Dial Transplant (2011) 0.80
Long-term, sub-clinical cardiac and renal complications in patients with multiple relapses of thrombotic thrombocytopenic purpura. Br J Haematol (2010) 0.80
PPAR-alpha ligands inhibit H2O2-mediated activation of transforming growth factor-beta1 in human mesangial cells. Antioxid Redox Signal (2002) 0.80
A phase I study of high-dose interleukin-2 with sorafenib in patients with metastatic renal cell carcinoma and melanoma. J Immunother (2014) 0.80
Brodifacoum induces early hemoglobinuria and late hematuria in rats: novel rapid biomarkers of poisoning. Am J Nephrol (2015) 0.80
Screening for blunt cerebrovascular injury: selection criteria for use of angiography. J Neurosurg (2010) 0.79
A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy. Nephrol Dial Transplant (2010) 0.79
A quantitative assessment of glycolipid and protein associated with paired helical filament preparations from Alzheimer's diseased brain. J Alzheimers Dis (2001) 0.78
Chronic kidney disease: fluid in chronic kidney disease-how much is too much? Nat Rev Nephrol (2013) 0.78
A polymorphism in the type one complement receptor (CR1) involves an additional cysteine within the C3b/C4b binding domain that inhibits ligand binding. Mol Immunol (2007) 0.78
Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression. Am J Kidney Dis (2005) 0.77
Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care? Nephron Clin Pract (2010) 0.77
Relapse or worsening of nephrotic syndrome in idiopathic membranous nephropathy can occur even though the glomerular immune deposits have been eradicated. Nephron Clin Pract (2011) 0.77
Pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis. Ann Intern Med (2010) 0.77
A proposal for standardized grading of chronic changes in native kidney biopsy specimens. Kidney Int (2017) 0.76
An approach to validating criteria for proteinuric flare in systemic lupus erythematosus glomerulonephritis. Arthritis Rheum (2011) 0.76
Lupus nephritis: guidelines for lupus nephritis--more recommendations than data? Nat Rev Nephrol (2012) 0.76
Unexpected sensitivity of synthetic Renilla luciferase control vectors to treatment with a cyclopentenone prostaglandin. Biotechniques (2003) 0.76
Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med (2008) 0.75
Cardiac stress test as a risk-stratification tool for posttransplant cardiac outcomes in diabetic kidney transplant recipients. Transplantation (2012) 0.75
Hemodialysis access monitoring and surveillance, how and why? Front Biosci (Elite Ed) (2012) 0.75
Unexplained severe acute kidney injury with rapid recovery of kidney function 11 months later after the start of high-dose steroid therapy. Clin Nephrol (2014) 0.75
Should the target for blood pressure control specify both a systolic and a diastolic component? Curr Hypertens Rep (2005) 0.75